Unknown PHASE1 INTERVENTIONAL 1-arm NCT05651074

Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects

A Pharmacokinetic/Pharmacodynamic Study to Evaluate the Effect of Omeprazole of Vicagrel in Healthy Subjects

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Updated 6 times since 2023 Last updated: Jan 29, 2023 Started: Nov 14, 2022 Primary completion: Feb 28, 2023 Completion: Apr 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy Subjects, this trial is ongoing. The trial is conducted by Jiangsu vcare pharmaceutical technology co., LTD and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Dec 2024 — Sep 2025 [monthly]

Unknown PHASE1

Status: Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Feb 2023 — Jul 2024 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Jan 2023 — Feb 2023 [monthly]

Recruiting PHASE1

First recorded

Nov 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu vcare pharmaceutical technology co., LTD

Data source: Jiangsu vcare pharmaceutical technology co., LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changchun, China